SCHEMBL13051146

SCHEMBL13051146

CNC(=O)C(NC(=O)OC)C(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 4/20 0.48
MMP3 P08254 17/20 0.45
MMP1 P03956 16/20 0.45
MMP2 P08253 14/20 0.45
MMP9 P14780 9/20 0.45
MMP8 P22894 4/20 0.45
MMP13 P45452 3/20 0.45
MMP7 P09237 4/20 0.44
MMP14 P50281 2/20 0.44
TNF P01375 2/20 0.44
MMP20 O60882 1/20 0.44
ADAMTS4 O75173 1/20 0.44
MMP10 P09238 1/20 0.44
MMP12 P39900 1/20 0.44
MMP15 P51511 1/20 0.44
MMP16 P51512 1/20 0.44
MMP25 Q9NPA2 1/20 0.44
MMP26 Q9NRE1 1/20 0.44
ADAMTS5 Q9UNA0 1/20 0.44
MMP24 Q9Y5R2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1176007 0.84 CA1 (0.47) ADAM17MMP3MMP1MMP2MMP9
SCHEMBL1176010 0.84 CA1 (0.47) ADAM17MMP3MMP1MMP2MMP9
SCHEMBL4293013 0.84 CA1 (0.47) ADAM17MMP3MMP1MMP2MMP9
SCHEMBL9972547 0.82 MMP1 (0.47) ADAM17MMP3MMP1MMP2MMP9
SCHEMBL6098 0.82 HIF1A (0.34) ADAM17MMP3MMP1MMP2MMP9
SCHEMBL1706304 0.82 HIF1A (0.34) ADAM17MMP3MMP1MMP2MMP9
SCHEMBL8234485 0.81 MMP3 (0.47) ADAM17MMP3MMP1MMP2MMP9
Hydrochloric Acid SCHEMBL2286815 0.80 HIF1A (0.33) ADAM17MMP3MMP1MMP2MMP9
SCHEMBL192054 0.78 CA2 (0.40) ADAM17
SCHEMBL3265337 0.78 ALDH1A1 (0.33) ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018032468-A1 HETEROCYCLE-SUBSTITUED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME CORP. (US) 2018-02-22 WO disclosed
WO-2010144869-A2 PROTEASE INHIBITORS NEKTAR THERAPEUTICS (US) 2010-12-16 WO disclosed